By Dean Seal Shares of Adial Pharmaceuticals advanced after the company regained compliance with Nasdaq listing requirements. The stock was up 6.6% at $2.27.
By Chris Wack Adial Pharmaceuticals shares were up 5%, to $2.90, after the biopharmaceutical company was awarded a notice of allowance for a patent. The.